The vision of MetaHeps is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach:

Using our patented technology will

 

 improve benefit-risk assessment by providing unprecedeneted data on DILI cases

 

avoid financial losses due to unnecessary drug attrition

 

protect patients at risk by the developemt of novel biomarkers

 

reduce risks of drug development and provide patients access to urgently needed treatments